Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 07, 2024

BUY
$76.22 - $98.51 $15,244 - $19,702
200 New
200 $19,000
Q1 2023

May 12, 2023

SELL
$87.74 - $117.27 $8,774 - $11,727
-100 Reduced 33.33%
200 $19,000
Q4 2022

Feb 14, 2023

BUY
$80.93 - $108.63 $24,279 - $32,589
300 New
300 $31,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Ica Group Wealth Management, LLC Portfolio

Follow Ica Group Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ica Group Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ica Group Wealth Management, LLC with notifications on news.